Hello again, I'm really not trying to ride your coattails. I've been slowly adjusting my alerts for oversold biotechs with good one-year volatility. Seems like every time I find one, you're already on it.
It was between ORPN and CYTX (may take longer to gain confidence back after the offer and split), and ORPN won for best possible up-swing.